Steven Pearson, MD, MSc
Seminar date: 9/19/2018
Description: Health economists continue to debate the proper relationship between cost-effectiveness analyses (CEA) and considerations of affordability. In this presentation I will discuss different ways that CEA and affordability can be integrated for decision-making and reflect on options for developing a potential budget impact threshold for new drugs tailored to the VA health care system. Target audience: Researchers and staff within the VA conducting or using CEA or budget impact analyses to guide decision-making.
DOWNLOAD: PDF handout | Audio only (mp3) | transcript